Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment

Several randomized controlled trials have shown a benefit of high-dose intensive statin treatment in reducing risk of death and second cardiovascular disease (CVD) events in patients previously diagnosed with an acute coronary syndrome (ACS). Non-randomized studies in clinical settings support these...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockberg, J., Jørgensen, L., Taylor, B., Sobocki, P., Johansson, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374870/
https://www.ncbi.nlm.nih.gov/pubmed/28373930
http://dx.doi.org/10.1016/j.pmedr.2017.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374870/
https://www.ncbi.nlm.nih.gov/pubmed/28373930
http://dx.doi.org/10.1016/j.pmedr.2017.03.001

Ejemplares similares